Spinal Cord Stimulation Devices Market By Product (Rechargeable devices, Non-rechargeable devices), By Indication (Failed back surgery syndrome, Complex regional pain syndrome, Degenerative disc disease, Others), By End User (Hospitals, Ambulatory surgical centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
Spinal cord stimulation is a medical technique that involves the use of an implanted device that delivers electrical impulses to spinal cord, with the aim of reducing pain and improving function in patients with chronic pain conditions. The spinal cord stimulation device consists of a small battery-powered generator that is implanted under the skin, in the lower back and one or more leads that are implanted in the epidural space near the spinal cord. The leads are connected to the generator and deliver electrical impulses to the spinal cord, which interrupt or block pain signals from reaching the brain. Spinal cord stimulation devices are used to treat a variety of conditions, such as failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), degenerative disc disease (DDD), and painful diabetic neuropathy (PDN). Spinal cord stimulation devices are available in different types and designs, with varying features and capabilities. Different types of spinal cord stimulation such as rechargeable and non-rechargeable devices are designed to address different patients’ needs and provide customized treatment options.
The major factors driving the growth of spinal cord stimulation devices market are increase in number of people suffering from chronic pain conditions, technological advancements in spinal cord stimulation devices, and rise in adoption of spinal cord stimulation devices. Chronic pain can be caused by a variety of conditions, such as failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), degenerative disc disease (DDD), and diabetic neuropathy. These conditions can be debilitating, affecting a person's quality of life and requiring long-term management. Spinal cord stimulation devices have emerged as an effective treatment option for patients suffering from chronic pain conditions who have not responded to other forms of therapy. In addition, spinal cord stimulation devices work by delivering electrical impulses to the spinal cord, disrupting the transmission of pain signals to the brain.
Further, technological advancements in spinal cord stimulation devices have made the devices smaller, flexible, and more effective. For instance, newer devices use high-frequency stimulation, which can provide pain relief without causing the tingling or prickling sensations associated with traditional low-frequency stimulation. In addition, other advances include the development of rechargeable batteries and wireless devices, which improve patient comfort and convenience. These technological advancements are expected to drive the demand for spinal cord stimulation devices as patients and physicians seek out more effective and user-friendly devices.
Moreover, the world’s population is aging rapidly, and this demographic shift is expected to drive the demand for spinal cord stimulation devices. Older adults are more likely to suffer from chronic pain conditions, and as the population ages, the number of people in need of spinal cord stimulation therapy is expected to grow. For instance, according to the U.S. Census Bureau 2022, more than 56 million adults aged 65 and older live in the U.S., accounting for about 16.9% of the nation’s population; thus, rise in geriatric population is anticipated to fuel the growth of market.
The spinal cord stimulation devices market is segmented into product, indication, end user, and region. On the basis of product, the market is bifurcated into rechargeable devices and non-rechargeable devices. Depending on indication, it is categorized into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease, and others. By end user, it is segregated into hospital, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East Africa)
Major key players that operate in the global spinal cord stimulation devices market are Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Beijing PINS Medical Co., Ltd, Saluda Medical Pty Ltd., Nalu Medical, Inc., BIOTRONIK, GIMER MEDICAL, and Teliatry, Inc. The key players have adopted strategies such as acquisition, product launch, product approval, and expansion to expand their product portfolio.
Key Benefits For StakeholdersThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the spinal cord stimulation devices market analysis from 2022 to 2032 to identify the prevailing spinal cord stimulation devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the spinal cord stimulation devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global spinal cord stimulation devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market SegmentsBy IndicationFailed back surgery syndrome
Complex regional pain syndrome
Degenerative disc disease
Others
By ProductRechargeable devices
Non-rechargeable devices
By End UserHospitals
Ambulatory surgical centers
Others
By RegionNorth America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Latin America
Middle East Africa
Key Market Players
Boston Scientific Corporation
Beijing PINS Medical Co., Ltd
Medtronic plc
Abbott Laboratories
BIOTRONIK SE & Co. KG
Saluda Medical Pty Ltd.
Nalu Medical, Inc.
GIMER MEDICAL
Teliatry, Inc.
Nevro Corporation
Please Note: It will take 7-10 business days to complete the report upon order confirmation.